Related Experiment Video

Updated: Oct 16, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cells

J M Darbon1, M Penary, N Escalas

  • 1Laboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération Cellulaire, UMR 5088 CNRS, Université Paul Sabatier, 118 Route de Narbonne, 31062 Toulouse Cedex, France. darbon@cict.fr

The Journal of Biological Chemistry
|May 16, 2000
PubMed

Insights

Genistein, a soy isoflavone, halts melanoma cell growth by blocking Cdk1 dephosphorylation. This cancer prevention mechanism differs from genotoxic agents, highlighting distinct G2 checkpoint pathways.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Cancer Research

Background:

  • Genistein, a soy isoflavone, shows potential in cancer prevention.
  • Previous studies demonstrated genistein inhibits melanoma cell proliferation via G2 arrest.

Purpose of the Study:

  • To elucidate the molecular mechanisms of genistein-induced G2 cell cycle arrest in melanoma cells.
  • To compare the G2 checkpoint activation pathways of genistein with those of genotoxic agents.

Main Methods:

  • Investigated the role of Cdc25C and Cdk1 in genistein-induced G2 arrest.
  • Utilized caffeine and etoposide to analyze cell cycle bypass and checkpoint activation.
  • Assessed Chk2 and p53 activation and DNA damage response.

Main Results:

  • Genistein impairs Cdc25C-dependent Cdk1 dephosphorylation, causing G2 arrest.
  • Caffeine overrides genistein-induced arrest, while etoposide's block is not bypassed.
  • Genistein activates Chk2 similarly to genotoxic agents but induces less DNA damage.

Conclusions:

  • Genistein-induced G2 arrest involves distinct pathways compared to genotoxic agents like etoposide and adriamycin.
  • The findings suggest novel mechanisms for genistein's anti-cancer effects.
  • Understanding these pathways could inform cancer prevention strategies.

More Related Videos

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts10:55

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts

Published on: November 5, 2012

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...